首页> 美国卫生研究院文献>Avicenna Journal of Medical Biotechnology >Association of CALHM1 Gene Polymorphism with Late Onset Alzheimers Disease in Iranian Population
【2h】

Association of CALHM1 Gene Polymorphism with Late Onset Alzheimers Disease in Iranian Population

机译:CALHM1基因多态性与伊朗人群晚期阿尔茨海默氏病的关联

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Alzheimer's disease (AD) is a genetically heterogeneous neurodegenerative disease and Late-Onset type (LOAD) is the most common form of dementia affecting people over 65 years old. CALHM1 (P86L) encodes a transmembrane glycoprotein that controls cytosolic Ca2+ concentrations and Aβ levels and P86L polymorphism in this gene is significantly associated with LOAD in independent case controls in a number of studies. This study was performed to determine whether this polymorphism contributes to the risk for LOAD in Iranian population. One hundred and forty one AD patients and 141 healthy controls were recruited in this study. After extraction of genomic DNA, the genotype and allele frequencies were determined in case and control subjects using PCR/RFLP method. The statistical analysis showed a significant difference in the heterozygote genotype frequency in case and control groups and polymorphic allele had a protective role between two groups. Also after stratifying the subjects by their APOE-ɛ4 status, no significant association was observed. Our study suggests that P86L polymorphism could be a protective factor for late-onset Alzheimer's disease (LOAD) in Iranian population. However, to confirm these results, further study with a bigger sample size may be required.
机译:阿尔茨海默氏病(AD)是遗传异质性神经退行性疾病,迟发型(LOAD)是影响65岁以上人群的最常见的痴呆形式。在许多研究中,CALHM1(P86L)编码一个跨膜糖蛋白,该蛋白控制细胞质中Ca 2 + 的浓度和Aβ水平,并且该基因中的P86L多态性与LOAD显着相关。进行这项研究是为了确定这种多态性是否有助于伊朗人群中LOAD的风险。在这项研究中招募了141名AD患者和141名健康对照者。提取基因组DNA后,使用PCR / RFLP方法确定病例和对照受试者的基因型和等位基因频率。统计分析表明,病例组和对照组的杂合子基因型频率存在显着差异,而多态性等位基因在两组之间具有保护作用。同样按照受试者的APOE-4身份对受试者进行分层后,也未发现明显的关联。我们的研究表明,P86L多态性可能是伊朗人群晚发性阿尔茨海默氏病(LOAD)的保护因素。但是,为证实这些结果,可能需要进一步进行更大样本量的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号